Literature DB >> 8184112

Malignant glioma: patterns of failure following individually tailored limited volume irradiation.

C F Hess1, J C Schaaf, R D Kortmann, M Schabet, M Bamberg.   

Abstract

Treatment outcome was analyzed for 66 patients with malignant glioma treated with individually CT-planned multifield irradiation techniques. Total doses of 60 Gy were given, with the planning target volume (PTV) including 2 cm beyond the tumour indicated by preoperative CT examination. Median survival was 14 months, and 86% of recurrences occurred in the treated volume. Our results suggest that the used PTV and radiation technique should be appropriate in radiotherapy of malignant glioma.

Entities:  

Mesh:

Year:  1994        PMID: 8184112     DOI: 10.1016/0167-8140(94)90044-2

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  33 in total

Review 1.  Biomarkers for glioma immunotherapy: the next generation.

Authors:  Jennifer S Sims; Timothy H Ung; Justin A Neira; Peter Canoll; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2015-02-28       Impact factor: 4.130

2.  Immediate post-operative MRI suggestive of the site and timing of glioblastoma recurrence after gross total resection: a retrospective longitudinal preliminary study.

Authors:  Thibault Smets; Tévi Morel Lawson; Cécile Grandin; Aleksandar Jankovski; Christian Raftopoulos
Journal:  Eur Radiol       Date:  2013-01-12       Impact factor: 5.315

3.  Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed?

Authors:  Michela Buglione; Sara Pedretti; Pietro Luigi Poliani; Roberto Liserre; Stefano Gipponi; Giannantonio Spena; Paolo Borghetti; Ludovica Pegurri; Federica Saiani; Luigi Spiazzi; Giulia Tesini; Chiara Uccelli; Luca Triggiani; Stefano Maria Magrini
Journal:  J Neurooncol       Date:  2016-03-30       Impact factor: 4.130

4.  Evaluation of current clinical target volume definitions for glioblastoma using cell-based dosimetry stochastic methods.

Authors:  L Moghaddasi; E Bezak; W Harriss-Phillips
Journal:  Br J Radiol       Date:  2015-07-03       Impact factor: 3.039

5.  Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design.

Authors:  Jordan A Holmes; Anna K Paulsson; Brandi R Page; Lance D Miller; Wennuan Liu; Jianfeng Xu; William H Hinson; Glenn J Lesser; Adrian W Laxton; Stephen B Tatter; Waldemar Debinski; Michael D Chan
Journal:  J Neurooncol       Date:  2015-07-18       Impact factor: 4.130

6.  Patterns of imaging failures in glioblastoma patients treated with chemoradiation: a retrospective study.

Authors:  Hubert Pan; John Alksne; Arno J Mundt; Kevin T Murphy; Mariel Cornell; Santosh Kesari; Joshua D Lawson
Journal:  Med Oncol       Date:  2011-11-23       Impact factor: 3.064

7.  Role of a DNA damage checkpoint pathway in ionizing radiation-induced glioblastoma cell migration and invasion.

Authors:  Issai Vanan; Zhiwan Dong; Elena Tosti; Gregg Warshaw; Marc Symons; Rosamaria Ruggieri
Journal:  Cell Mol Neurobiol       Date:  2012-05-03       Impact factor: 5.046

8.  A novel tool to analyze MRI recurrence patterns in glioblastoma.

Authors:  Wolfgang Wick; Roger Stupp; Anna-Carina Beule; Jacoline Bromberg; Antje Wick; Ulrike Ernemann; Michael Platten; Christine Marosi; Warren P Mason; Martin van den Bent; Michael Weller; Chris Rorden; Hans-Otto Karnath
Journal:  Neuro Oncol       Date:  2008-07-31       Impact factor: 12.300

9.  Stereotactic radiosurgery for glioblastoma: retrospective analysis.

Authors:  Tithi Biswas; Paul Okunieff; Michael C Schell; Therese Smudzin; Webster H Pilcher; Robert S Bakos; G Edward Vates; Kevin A Walter; Andrew Wensel; David N Korones; Michael T Milano
Journal:  Radiat Oncol       Date:  2009-03-17       Impact factor: 3.481

10.  Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas.

Authors:  Bronwyn Stall; Leor Zach; Holly Ning; John Ondos; Barbara Arora; Uma Shankavaram; Robert W Miller; Deborah Citrin; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2010-01-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.